ViTAA Medical’s aortic surgery planning tool has gained clearance from the US Food and Drug Administration (FDA), representing the first milestone in the company’s aim to bring a full spectrum aortic care platform to market.

ViTAA’s AiORTA Plan is an AI-based tool that is designed to assist physicians in their preparations for complex aortic procedures.

Using AI to automatically generate key preoperative measurements for aortic surgical cases, such as aneurysm segmentation, centreline generation, and volumetric analysis protocols, the cloud-based tool aims to improve precision and reproducibility in aortic surgical interventions and reduce manual planning work.